With President Obama’s reforms to the health care system, pharmaceutical companies will be required to disclose payments made to doctors in exchange for research, consulting and talks. Consumer protection advocates and members of Congress in support of this requirement, argue this ultimately benefits patients who will receive the best drug prescription without a conflict of interest.
Adelia says
Much better if the implementation will pursue because it is a help of poor who have problem in financial. Mostly patient problem don’t have enough money to buy medicine because it is very expensive.